|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- Revista de Științe ale Sănătății din Moldova
- Revista de Științe ale Sănătății din Moldova : Moldovan Journal of Health Sciences 2024 Vol. 11, Issue 2
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/30011
Title: | Dyslipidemia in patients with cardiovascular diseases |
Authors: | Joseph, Daniel Aswin, George Romaniuc, Iuliana |
Keywords: | cardiovascular diseases;dyslipidemia;atherosclerosis |
Issue Date: | 2024 |
Publisher: | Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova |
Citation: | JOSEPH, Daniel; ASWIN, George; ROMANIUC, Iuliana. Dyslipidemia in patients with cardiovascular diseases. In: Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences. 2024, vol. 11, nr. 3, anexa 2, p. 234. ISSN 2345-1467. |
Abstract: | Background. Dyslipidemia represents the consequence
of an abnormal lipids level in the blood, determined by
an increased total cholesterol, low- density lipoprotein
cholesterol, triglycerides or a decrease in high- density
lipoprotein level in the blood, being a significant factor
in the atherosclerosis disease development. Purpose of
the research: Evaluation of dyslipidemia in patients with
cardiovascular diseases. Material and methods. We conducted a hospital-based case series study at the Cardiology
department of Holy Trinity Hospital The study involved 40
patients diagnosed with dyslipidemia and cardiovascular
diseases in the year 2022. Results. Our study of 40 highrisk cardiovascular patients revealed critical findings. The
cohort had a mean age of 65 years old, 45% males and
55% females. In the study group, 75% (30 patients) had
hypertension and 100% dyslipidemia. The mean value of the BMI was 29,4 kg/m², above the normal threshold and
indicating overweight. Statin usage was observed in 85%
(34 patients) and 70% (28 patients) were administered
ACE inhibitors. The mean lipid profile values were total
cholesterol 242 mg/dL, triglycerides 178 mg/dL, HDL-C 46
mg/dL and LDL-C 167 mg/dL. The statistical correlation
test demonstrated a correlation between hypertension,
BMI and dyslipidemia (p < 0.05). Conclusions. All studied
patients had dyslipidemia, with abnormal lipid level, therefore confirming the research hypothesis. The study findings
highlight the importance of dyslipidemia management, by
lipid-lowering therapy along with lifestyle modification can
reduce the risk of development and progression of atherosclerosis disease and cardiovascular events. |
metadata.dc.relation.ispartof: | Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences |
URI: | https://cercetare.usmf.md/sites/default/files/inline-files/MJHS_11_3_2024_anexa2__site.pdf http://repository.usmf.md/handle/20.500.12710/30011 |
ISSN: | 2345-1467 |
Appears in Collections: | Revista de Științe ale Sănătății din Moldova : Moldovan Journal of Health Sciences 2024 Vol. 11, Issue 2
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|